Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Zhejiang Wecome Pharmaceutical Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Zhejiang Wecome Pharmaceutical has a total shareholder equity of CN¥1.3B and total debt of CN¥332.2M, which brings its debt-to-equity ratio to 24.9%. Its total assets and total liabilities are CN¥1.8B and CN¥502.8M respectively.
Anahtar bilgiler
24.9%
Borç/özkaynak oranı
CN¥332.16m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CN¥320.58m |
| Eşitlik | CN¥1.34b |
| Toplam yükümlülükler | CN¥502.79m |
| Toplam varlıklar | CN¥1.84b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 300878's short term assets (CN¥783.9M) exceed its short term liabilities (CN¥175.9M).
Uzun Vadeli Yükümlülükler: 300878's short term assets (CN¥783.9M) exceed its long term liabilities (CN¥326.9M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 300878's net debt to equity ratio (0.9%) is considered satisfactory.
Borcun Azaltılması: 300878's debt to equity ratio has reduced from 25.7% to 24.9% over the past 5 years.
Borç Kapsamı: 300878's operating cash flow is negative, therefore debt is not well covered.
Faiz Kapsamı: Insufficient data to determine if 300878's interest payments on its debt are well covered by EBIT.